HLA-B55: Difference between revisions
Appearance
Content deleted Content added
m clean up- spelling of "et al." using AWB |
Entranced98 (talk | contribs) Adding local short description: "Human leukocyte antigen serotype", overriding Wikidata description "HLA-B serotype" |
||
(18 intermediate revisions by 14 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Human leukocyte antigen serotype}} |
|||
{| id="drugInfoBox" style="float: right; clear: right; margin: 0 0 0.5em 1em; background: #ffffff;" class="toccolours" border=0 cellpadding=0 align=right width="240px" |
{| id="drugInfoBox" style="float: right; clear: right; margin: 0 0 0.5em 1em; background: #ffffff;" class="toccolours" border=0 cellpadding=0 align=right width="240px" |
||
|- |
|- |
||
| align="center" colspan="3" | |
| align="center" colspan="3" | |
||
|- style="text-align: center; line-height: 1.00;background:#eeeeee" |
|- style="text-align: center; line-height: 1.00;background:#eeeeee" |
||
| colspan="3" color="white" | |
| colspan="3" color="white" | |
||
|- |
|- |
||
| align="center" colspan="2" | |
| align="center" colspan="2" | |
||
|- |
|- |
||
| align="center" colspan="2" | <div style="font-size:medium; line-height:120%;">major histocompatibility complex (human), class I, B55</div> |
| align="center" colspan="2" | <div style="font-size:medium; line-height:120%;">major histocompatibility complex (human), class I, B55</div> |
||
|- |
|- |
||
| bgcolor="#e7dcc3" | Alleles |
| bgcolor="#e7dcc3" | Alleles |
||
| bgcolor="#eeeeee" | B*5501, B*5502< |
| bgcolor="#eeeeee" | B*5501, B*5502<br> |
||
|- |
|- |
||
| colspan="2" bgcolor="#dddddd" | '''Structure''' (See [[HLA-B]]) |
| colspan="2" bgcolor="#dddddd" | '''Structure''' (See [[HLA-B]]) |
||
|- |
|- |
||
| bgcolor="#e7dcc3" | [[ |
| bgcolor="#e7dcc3" | [[Human Genome Organisation|Symbol(s)]] |
||
| bgcolor="#eeeeee" | [http://www.gene.ucl.ac.uk/nomenclature/data/get_data.php?hgnc_id=4932 HLA-B] |
| bgcolor="#eeeeee" | [https://web.archive.org/web/20070821210135/http://www.gene.ucl.ac.uk/nomenclature/data/get_data.php?hgnc_id=4932 HLA-B] |
||
|- |
|- |
||
| bgcolor="#e7dcc3" Rowspan = 2 | [[European Bioinformatics Institute|EBI-HLA]] |
| bgcolor="#e7dcc3" Rowspan = 2 | [[European Bioinformatics Institute|EBI-HLA]] |
||
Line 22: | Line 23: | ||
| bgcolor="#eeeeee" | [http://www.ebi.ac.uk/cgi-bin/imgt/hla/get_allele.cgi?B*550201 B*5502] |
| bgcolor="#eeeeee" | [http://www.ebi.ac.uk/cgi-bin/imgt/hla/get_allele.cgi?B*550201 B*5502] |
||
|- |
|- |
||
| bgcolor="#e7dcc3" | [[Locus (genetics)|Locus]] |
| bgcolor="#e7dcc3" | [[Locus (genetics)|Locus]] |
||
| bgcolor="#eeeeee" | [[Chromosome 6 (human)|chr.6]] ''[ |
| bgcolor="#eeeeee" | [[Chromosome 6 (human)|chr.6]] ''[https://www.ncbi.nlm.nih.gov/Omim/getmap.cgi?chromosome=6p21.31 6p21.31]'' |
||
|- |
|- |
||
|} |
|} |
||
'''HLA-B55''' (B55) is an [[Human leukocyte antigen|HLA]]-[[HLA-B|B]] [[serotype]]. B55 is a [[split antigen]] from the [[HLA-B22|B22]] [[broad antigen]], sister serotypes are [[HLA-B54|B54]] and [[HLA-B56|B56]]. The serotype identifies the more common HLA-B*55 gene products.<ref name="pmid15787720">{{cite journal |
'''HLA-B55''' (B55) is an [[Human leukocyte antigen|HLA]]-[[HLA-B|B]] [[serotype]]. B55 is a [[split antigen]] from the [[HLA-B22|B22]] [[broad antigen]], sister serotypes are [[HLA-B54|B54]] and [[HLA-B56|B56]]. The serotype identifies the more common HLA-B*55 gene products.<ref name="pmid15787720">{{cite journal |pmc=2848993 |year=2010 |last1=Marsh |first1=S. G. |title=Nomenclature for factors of the HLA system, 2010 |journal=Tissue Antigens |volume=75 |issue=4 |pages=291–455 |last2=Albert |first2=E. D. |last3=Bodmer |first3=W. F. |last4=Bontrop |first4=R. E. |last5=Dupont |first5=B. |last6=Erlich |first6=H. A. |last7=Fernández-Viña |first7=M. |last8=Geraghty |first8=D. E. |last9=Holdsworth |first9=R. |last10=Hurley |first10=C. K. |last11=Lau |first11=M. |last12=Lee |first12=K. W. |last13=Mach |first13=B. |last14=Maiers |first14=M. |last15=Mayr |first15=W. R. |last16=Müller |first16=C. R. |last17=Parham |first17=P. |last18=Petersdorf |first18=E. W. |last19=Sasazuki |first19=T. |last20=Strominger |first20=J. L. |last21=Svejgaard |first21=A. |last22=Terasaki |first22=P. I. |last23=Tiercy |first23=J. M. |last24=Trowsdale |first24=J. |pmid=20356336 |doi=10.1111/j.1399-0039.2010.01466.x }}</ref> (For terminology help see: [[HLA-A#Historical Guide to Understanding Nomenclature|HLA-serotype tutorial]]) |
||
==Serotype== |
==Serotype== |
||
B*55:03 is one of the four B alleles that reacts with neither Bw4 nor Bw6. The others are [[HLA-B18|B*18:06]], [[HLA-B46|B*46:01]], and [[HLA-B73|B*73:01]].<ref>{{cite journal |last1=Voorter |first1=CE |last2=van der Vlies |first2=S |last3=Kik |first3=M |last4=van den Berg-Loonen |first4=EM |title=Unexpected Bw4 and Bw6 reactivity patterns in new alleles. |journal=Tissue Antigens |date=October 2000 |volume=56 |issue=4 |pages=363–70 |pmid=11098937 |doi=10.1034/j.1399-0039.2000.560409.x }}</ref> |
|||
{| border="0" cellspacing="0" cellpadding="0" style="text-align:center; background:#ffffff; margin-right: 1em; border:2px #e0e0ff solid;" |
{| border="0" cellspacing="0" cellpadding="0" style="text-align:center; background:#ffffff; margin-right: 1em; border:2px #e0e0ff solid;" |
||
|+ B55 and B22 serotype recognition of some HLA B*55 allele-group gene products<ref>[http://www.ebi.ac.uk/imgt/hla/allele.html derived from IMGT/HLA]</ref> |
|+ B55 and B22 serotype recognition of some HLA B*55 allele-group gene products<ref>[http://www.ebi.ac.uk/imgt/hla/allele.html derived from IMGT/HLA]</ref> |
||
|- style="background:#f0f0ff" |
|- style="background:#f0f0ff" |
||
| style="width:60px" | B*55 || style="width:60px" | '''B55''' |
| style="width:60px" | B*55 || style="width:60px" | '''B55''' |
||
| style="width:60px" | B22 || style="width:60px" | Sample |
| style="width:60px" | B22 || style="width:60px" | Sample |
||
|- style="background:#f0f0ff" |
|- style="background:#f0f0ff" |
||
| allele || % || % || size (N) |
| allele || % || % || size (N) |
||
|- |
|- |
||
| style = "background:#e8e8f8" | 5501 || 92 || 5 || 453 |
| style = "background:#e8e8f8" | 5501 || 92 || 5 || 453 |
||
|- |
|- |
||
| style = "background:#e8e8f8" | 5502 || 84 || 2 || 309 |
| style = "background:#e8e8f8" | 5502 || 84 || 2 || 309 |
||
|} |
|} |
||
Line 47: | Line 50: | ||
|+ '''HLA B*5501 frequencies''' |
|+ '''HLA B*5501 frequencies''' |
||
|- style="background:#efe5ef" |
|- style="background:#efe5ef" |
||
| || || freq |
| || || freq |
||
|- style="background:#eee5ef" |
|- style="background:#eee5ef" |
||
| ref. || align="left" |Population || style="width:50px" | (%) |
| ref. || align="left" |Population || style="width:50px" | (%) |
||
|- |
|- |
||
| <ref name = "pmid12753660">{{cite journal | |
| <ref name = "pmid12753660">{{cite journal |vauthors=Middleton D, Menchaca L, Rood H, Komerofsky R | title = New allele frequency database | journal = Tissue Antigens | volume = 61 | issue = 5 | pages = 403–7 | year = 2003 | pmid = 12753660 | doi =10.1034/j.1399-0039.2003.00062.x | doi-access = free }}</ref> || align="left"|India New Delhi||3.8 |
||
|- |
|- |
||
| <ref name = "pmid12753660"/> || align="left"|Singapore Chinese Han||3.5 |
| <ref name = "pmid12753660"/> || align="left"|Singapore Chinese Han||3.5 |
||
Line 57: | Line 60: | ||
| <ref name = "pmid12753660"/> || align="left"|Spain Eastern Andalusia Gipsy||3.5 |
| <ref name = "pmid12753660"/> || align="left"|Spain Eastern Andalusia Gipsy||3.5 |
||
|- |
|- |
||
| <ref name = "pmid12753660"/> || align="left"|Georgia |
| <ref name = "pmid12753660"/> || align="left"|Georgia Tbilisi Kurds||3.4 |
||
|- |
|- |
||
| <ref name = "pmid12753660"/> || align="left"|India North Delhi||3.3 |
| <ref name = "pmid12753660"/> || align="left"|India North Delhi||3.3 |
||
Line 67: | Line 70: | ||
| <ref name = "pmid12753660"/> || align="left"|India North Hindus||2.9 |
| <ref name = "pmid12753660"/> || align="left"|India North Hindus||2.9 |
||
|- |
|- |
||
| <ref name = "pmid12753660"/> || align="left"|Georgia |
| <ref name = "pmid12753660"/> || align="left"|Georgia Tbilisi Georgians||2.8 |
||
|- |
|- |
||
| <ref name = "pmid12753660"/> || align="left"|Russia Tuva (2)||2.8 |
| <ref name = "pmid12753660"/> || align="left"|Russia Tuva (2)||2.8 |
||
Line 142: | Line 145: | ||
|} |
|} |
||
{{clear left}} |
|||
==References== |
==References== |
||
{{reflist}} |
{{reflist}} |
||
Line 147: | Line 151: | ||
{{HLA-B serotypes}} |
{{HLA-B serotypes}} |
||
{{DEFAULTSORT:Hla-B55}} |
|||
[[Category:HLA-B alleles|5]] |
[[Category:HLA-B alleles|5]] |
Latest revision as of 14:45, 26 June 2024
major histocompatibility complex (human), class I, B55
| ||
Alleles | B*5501, B*5502 | |
Structure (See HLA-B) | ||
Symbol(s) | HLA-B | |
EBI-HLA | B*5501 | |
B*5502 | ||
Locus | chr.6 6p21.31 |
HLA-B55 (B55) is an HLA-B serotype. B55 is a split antigen from the B22 broad antigen, sister serotypes are B54 and B56. The serotype identifies the more common HLA-B*55 gene products.[1] (For terminology help see: HLA-serotype tutorial)
Serotype
[edit]B*55:03 is one of the four B alleles that reacts with neither Bw4 nor Bw6. The others are B*18:06, B*46:01, and B*73:01.[2]
B*55 | B55 | B22 | Sample |
allele | % | % | size (N) |
5501 | 92 | 5 | 453 |
5502 | 84 | 2 | 309 |
Allele distribution
[edit]freq | ||
ref. | Population | (%) |
[4] | India New Delhi | 3.8 |
[4] | Singapore Chinese Han | 3.5 |
[4] | Spain Eastern Andalusia Gipsy | 3.5 |
[4] | Georgia Tbilisi Kurds | 3.4 |
[4] | India North Delhi | 3.3 |
[4] | France South East | 3.1 |
[4] | Israel Arab Druse | 3.0 |
[4] | India North Hindus | 2.9 |
[4] | Georgia Tbilisi Georgians | 2.8 |
[4] | Russia Tuva (2) | 2.8 |
[4] | Georgia Svaneti Svans | 2.5 |
[4] | Iran Baloch | 2.5 |
[4] | Singapore Thai | 2.5 |
[4] | Sudanese | 2.5 |
[4] | Mexico Mestizos | 2.4 |
[4] | Spain Eastern Andalusia | 2.4 |
[4] | Ireland South | 2.0 |
[4] | Azores Central Islands | 1.8 |
[4] | Bulgaria | 1.8 |
[4] | Israel Ashkenazi and Non Ashkenazi Jews | 1.8 |
[4] | Oman | 1.7 |
[4] | Tunisia Tunis | 1.7 |
[4] | India Andhra Pradesh Golla | 1.4 |
[4] | China Tibet | 1.3 |
[4] | Uganda Kampala | 1.2 |
[4] | Finland | 1.1 |
[4] | Portugal North | 1.1 |
[4] | Portugal Centre | 1.0 |
[4] | Singapore Riau Malay | 1.0 |
[4] | B*5502 | |
[4] | Taiwan Taroko | 14.5 |
[4] | American Samoa | 12.0 |
[4] | China Guangxi Maonan | 6.0 |
[4] | Japan Ainu Hokkaido | 5.0 |
[4] | China Tibet Autonomous Region Tibetans | 4.7 |
[4] | Singapore Chinese | 3.0 |
[4] | China Beijing Shijiazhuang Tianjian Han | 2.9 |
[4] | China North Han | 2.9 |
[4] | South Korea (3) | 2.7 |
[4] | Hong Kong Chinese | 2.2 |
[4] | Japan (5) | 2.2 |
[4] | Taiwan Ami | 2.0 |
[4] | Thailand (3) | 2.0 |
[4] | New Caledonia | 1.0 |
[4] | Philippines Ivatan | 1.0 |
References
[edit]- ^ Marsh, S. G.; Albert, E. D.; Bodmer, W. F.; Bontrop, R. E.; Dupont, B.; Erlich, H. A.; Fernández-Viña, M.; Geraghty, D. E.; Holdsworth, R.; Hurley, C. K.; Lau, M.; Lee, K. W.; Mach, B.; Maiers, M.; Mayr, W. R.; Müller, C. R.; Parham, P.; Petersdorf, E. W.; Sasazuki, T.; Strominger, J. L.; Svejgaard, A.; Terasaki, P. I.; Tiercy, J. M.; Trowsdale, J. (2010). "Nomenclature for factors of the HLA system, 2010". Tissue Antigens. 75 (4): 291–455. doi:10.1111/j.1399-0039.2010.01466.x. PMC 2848993. PMID 20356336.
- ^ Voorter, CE; van der Vlies, S; Kik, M; van den Berg-Loonen, EM (October 2000). "Unexpected Bw4 and Bw6 reactivity patterns in new alleles". Tissue Antigens. 56 (4): 363–70. doi:10.1034/j.1399-0039.2000.560409.x. PMID 11098937.
- ^ derived from IMGT/HLA
- ^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab ac ad ae af ag ah ai aj ak al am an ao ap aq ar as Middleton D, Menchaca L, Rood H, Komerofsky R (2003). "New allele frequency database". Tissue Antigens. 61 (5): 403–7. doi:10.1034/j.1399-0039.2003.00062.x. PMID 12753660.